Davis Aaron I. - 22 Mar 2022 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Mar 2022, 21:00:25 UTC
Prior SEC filing
18 Jan 2022
Next SEC filing
02 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron I. Davis

Key filing fact

Davis Aaron I. filed Form 4 for iTeos Therapeutics, Inc. (ITOS) on 24 Mar 2022.

Key facts

  • This page summarizes Davis Aaron I.'s Form 4 filing for iTeos Therapeutics, Inc. (ITOS).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Mar 2022, 21:00.

Change

  • Previous filing in this sequence was filed on 18 Jan 2022.
  • Current net transaction value: +$1,625,489.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ITOS transaction

Common Stock

Purchase

Transaction value
$678,938
Shares
+21,300
Change %
+0.68%
Price
$31.88
Shares after
3,163,358
Date
22 Mar 2022
Ownership
See footnote
Footnotes
F1
ITOS transaction

Common Stock

Purchase

Transaction value
$122,432
Shares
+3,700
Change %
+0.12%
Price
$33.09
Shares after
3,167,058
Date
22 Mar 2022
Ownership
See footnote
Footnotes
F1
ITOS transaction

Common Stock

Purchase

Transaction value
$167,139
Shares
+5,000
Change %
+0.16%
Price
$33.43
Shares after
3,172,058
Date
22 Mar 2022
Ownership
See footnote
Footnotes
F1
ITOS transaction

Common Stock

Purchase

Transaction value
$656,980
Shares
+20,000
Change %
+0.63%
Price
$32.85
Shares after
3,192,058
Date
23 Mar 2022
Ownership
See footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .